Exciting news from Cleerly! Their innovative approach to analyzing heart disease risk has earned its own CPT 1 code. This recognition supports streamlined, accessible insurance coverage, making Cleerly's plaque analyses more available for those needing preventive care.
It's been an exciting past few weeks at Cleerly! 🚀 1️⃣ We're thrilled to share that Cleerly's AI-powered plaque analysis has received a CPT Category I code from the American Medical Association (AMA)! This milestone, set to take effect in January 2026, paves the way for broader access to our new standard of precision heart care and solidifies our technology as an established diagnostic tool. Our team initiated this process with the AMA over 5 years ago, and we couldn't be more thankful to the many societies and physicians who supported us along the way. 2️⃣ Medicare Administrative Contractor, Noridian, has announced the expansion of Medicare coverage for Cleerly's AI-powered coronary CTA plaque analysis, effective December 7, 2024. This decision means nationwide Medicare coverage for eligible patients. The Cleerly team is ready to support physicians and patients as more individuals gain access to personalized, precise cardiac care. 💪❤️ 👉 Get the details on this important decision: https://lnkd.in/gNdygqab #HeartDisease #Cardiology #AIQCT #CardiacImaging #AIinHealthcare #MedTech #DigitalHealth